Latest Insider Transactions at Guardant Health, Inc. (GH)
This section provides a real-time view of insider transactions for Guardant Health, Inc. (GH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Guardant Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Guardant Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2022
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,544
+19.8%
|
-
|
|
Sep 09
2022
|
Amelia Merrill SVP, People |
SELL
Payment of exercise price or tax liability
|
Direct |
363
-1.58%
|
$21,417
$59.28 P/Share
|
|
Sep 09
2022
|
Amelia Merrill SVP, People |
BUY
Exercise of conversion of derivative security
|
Direct |
1,047
+4.36%
|
-
|
|
Sep 04
2022
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+7.11%
|
-
|
|
Sep 01
2022
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
364
-2.54%
|
$17,836
$49.07 P/Share
|
|
Sep 01
2022
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,052
+6.83%
|
-
|
|
Sep 01
2022
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,409
-6.59%
|
$69,041
$49.07 P/Share
|
|
Sep 01
2022
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,840
+11.73%
|
-
|
|
Sep 01
2022
|
Amelia Merrill SVP, People |
SELL
Payment of exercise price or tax liability
|
Direct |
219
-0.99%
|
$10,731
$49.07 P/Share
|
|
Sep 01
2022
|
Amelia Merrill SVP, People |
BUY
Exercise of conversion of derivative security
|
Direct |
631
+2.77%
|
-
|
|
Aug 17
2022
|
Kumud Kalia Chief Information Officer |
SELL
Open market or private sale
|
Direct |
2,000
-9.74%
|
$102,000
$51.39 P/Share
|
|
Aug 15
2022
|
Amelia Merrill SVP, People |
SELL
Payment of exercise price or tax liability
|
Direct |
219
-1.01%
|
$12,045
$55.04 P/Share
|
|
Aug 15
2022
|
Amelia Merrill SVP, People |
BUY
Exercise of conversion of derivative security
|
Direct |
631
+2.82%
|
-
|
|
Aug 12
2022
|
Amelia Merrill SVP, People |
SELL
Open market or private sale
|
Direct |
4,500
-18.21%
|
$243,000
$54.32 P/Share
|
|
Aug 11
2022
|
Amelia Merrill SVP, People |
SELL
Open market or private sale
|
Direct |
4,500
-15.41%
|
$238,500
$53.38 P/Share
|
|
Aug 11
2022
|
Amelia Merrill SVP, People |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+14.62%
|
$20,000
$4.18 P/Share
|
|
Aug 04
2022
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
796
+50.0%
|
-
|
|
Aug 01
2022
|
Amelia Merrill SVP, People |
SELL
Payment of exercise price or tax liability
|
Direct |
475
-2.2%
|
$22,800
$48.38 P/Share
|
|
Aug 01
2022
|
Amelia Merrill SVP, People |
BUY
Exercise of conversion of derivative security
|
Direct |
1,371
+5.97%
|
-
|
|
Jun 15
2022
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,198
+50.0%
|
-
|
|
Jun 15
2022
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,814
+23.6%
|
-
|
|
Jun 15
2022
|
Samir Kaul Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,814
+23.6%
|
-
|
|
Jun 15
2022
|
Vijaya Gadde Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,814
+21.77%
|
-
|
|
Jun 15
2022
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,688
-34.6%
|
$64,144
$38.42 P/Share
|
|
Jun 15
2022
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,879
+50.0%
|
-
|
|
Jun 15
2022
|
Bahija Jallal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,814
+19.67%
|
-
|
|
May 15
2022
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,286
-34.6%
|
$45,010
$35.91 P/Share
|
|
May 15
2022
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,717
+50.0%
|
-
|
|
Apr 15
2022
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,102
-7.66%
|
$78,242
$71.99 P/Share
|
|
Mar 10
2022
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$286,172
$58.74 P/Share
|
|
Mar 10
2022
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Feb 10
2022
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$360,182
$73.8 P/Share
|
|
Feb 10
2022
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Jan 15
2022
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,246
-37.67%
|
$95,942
$77.58 P/Share
|
|
Jan 15
2022
|
Michael Brian Bell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,308
+50.0%
|
-
|
|
Jan 10
2022
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$424,324
$86.08 P/Share
|
|
Jan 10
2022
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Dec 10
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$468,730
$95.59 P/Share
|
|
Dec 10
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Nov 23
2021
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
54,500
+0.49%
|
$5,123,000
$94.97 P/Share
|
|
Nov 23
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
54,500
+0.46%
|
$5,123,000
$94.93 P/Share
|
|
Nov 19
2021
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+1.37%
|
$4,900,000
$98.3 P/Share
|
|
Nov 19
2021
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+1.3%
|
$4,900,000
$98.33 P/Share
|
|
Nov 10
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$523,004
$106.38 P/Share
|
|
Nov 10
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Oct 11
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-54.86%
|
$508,202
$103.59 P/Share
|
|
Oct 11
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Sep 10
2021
|
Stanley J Meresman Director |
SELL
Open market or private sale
|
Direct |
4,934
-22.87%
|
$641,420
$130.18 P/Share
|
|
Sep 10
2021
|
Stanley J Meresman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,934
+35.43%
|
$24,670
$5.94 P/Share
|
|
Sep 09
2021
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
433
-2.92%
|
$56,290
$130.85 P/Share
|